AURKA Governs Self-Renewal Capacity in Glioma-Initiating Cells Via Stabilization/activation of Β-Catenin/wnt Signaling.

Zhibo Xia,Ping Wei,Heng Zhang,Zhiming Ding,Lixuan Yang,Zhengsong Huang,Nu Zhang

DOI: https://doi.org/10.1158/1541-7786.mcr-13-0044

2013-01-01

Molecular Cancer Research

Abstract:Glioma-initiating cells (GIC), which are characterized by their self-renewal capacity and tumorigenicity, were recently identified as a highly tumorigenic subpopulation of glioblastoma multiforme and are considered responsible for glioblastoma recurrence and chemo/radiation resistance. Previously, it was revealed that Wnt signaling activation is critical to the self-renewal of GICs. However, the molecular mechanism underlying the high expression of beta-catenin, the key transcription factor of the Wnt signaling pathway, remains elusive. In this investigation, it was determined that aurora kinase A (AURKA) regulates the self-renewal and tumorigenicity of GICs by stabilizing beta-catenin. In GICs, AURKA directly interacts with AXIN and disrupts the AXIN/GSK3 beta/beta-catenin destruction complex and stabilizes beta-catenin, thereby activating Wnt signaling to promote self-renewal. Stable knockdown of AURKA destabilizes beta-catenin by increasing phosphorylated beta-catenin bound to AXIN and suppresses Wnt signaling, which inhibits the ability of GICs to self-renew. This effect is rescued by expression of an AURKA kinase dead mutant, D274A, which lacks the ability to phosphorylate GSK3 beta, indicating that stabilization of beta-catenin by AURKA in GICs is independent from phosphorylation of GSK3 beta. Functional experiments confirm that inhibition of AUKRA in GICs could suppress their "stemness," self-renewal ability, and tumorigenicity both in vitro and in vivo, and these effects could be rescued by stabilized beta-catenin mutant. These findings indicate that AURKA competes away the binding of AXIN from beta-catenin, induces beta-catenin stabilization, and activates Wnt signaling in GICs. (C) 2013 AACR.